NOTE: This article is only available to subscribers. Subscribe now to gain access to all articles, read exclusive interviews with top scientists from around the world, and browse the site ad free. The first month is free.

Anti-cancer drug reverses Alzheimer’s disease deficits in mice

May 25, 2013

Anti-cancer drug reverses Alzheimer’s disease deficits in mice

The research examined previously published studies on the drug bexarotene, which is approved by the U.S. FDA for the treatment of cutaneous T cell lymphoma.

Researchers from the University of Pittsburgh Graduate School of Public Health have discovered that an anti-cancer drug reverses Alzheimer’s disease deficits in mice.

The researchers examined previously published studies on the drug bexarotene, which is approved by the FDA for the treatment of cutaneous T cell lymphoma.

Comments
Comments should take into account that readers may hold different opinions. With that in mind, please make sure comments are respectful, insightful, and remain focused on the article topic. In addition, readers can send us tips, press releases, or ideas for stories: tips@sciencerecorder.com
left_bottom